Multi-specific antibodies
Delve into the world of Multi-specific antibodies in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on Multi-specific antibodies to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.
European Commission Approves Betta’s Ensartinib as Gevalka – Next‑Generation ALK Inhibitor for Advanced NSCLC Marks Chinese Innovation’s Entry Into the EU Market
Betta Pharmaceuticals (SHE: 300558) announced that the Marketing Authorization Application (MAA) for ensartinib – submitted by Xcovery, its majority‑owned subsidiary – received approval from the European Commission. Indicated for the…
Empowering Chinese Pharma’s Global Expansion
Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
